ArticleNature communications2022

Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.

Chengyu Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.